Metagenomi TherapeuticsMGX
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 54 institutions reported holding Metagenomi Therapeutics Inc. (MGX) in their 13F filings, up 4 from Q1 2024. 14 opened new positions and 10 sold out. The largest holders were Novo Holdings A/S ($7.3M), Ra Capital Management, L.P. ($6.0M) and Farallon Capital Management, L.L.C. ($5.5M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Metagenomi Therapeutics Inc.
- CUSIP
- 59102M104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $616K |
| Exits | 10 | $6.6M |
All 13F filers, Q1 2024 → Q2 2024: 981,347 shares bought and 1,998,780 shares sold, net −1,017,433 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 54 holders
| Novo Holdings A/S | 0.40% | Add +3.5% | 1,800,000 | $7.3M |
| Ra Capital Management, L.P. | 0.08% | Reduce -15.3% | 1,477,749 | $6.0M |
| Farallon Capital Management, L.L.C. | 0.03% | No change | 1,343,201 | $5.5M |
| PFM Health Sciences, LP | 0.29% | No change | 1,267,002 | $5.2M |
| HHLR Advisors, LTD. | 0.08% | No change | 777,768 | $3.2M |
| Citadel Advisors | 0.00% | Add +0.8% | 729,852 | $2.9M |
| Eventide Asset Management, LLC | 0.04% | No change | 583,041 | $2.4M |
| Sozo Ventures GP II, L.P. | 0.97% | No change | 581,577 | $2.4M |
| Deep Track Capital, LP | 0.06% | No change | 466,232 | $1.9M |
| BlackRock Inc. | 0.00% | Add +267.6% | 420,242 | $1.7M |
| Norges Bank | 0.00% | Add +233.8% | 360,202 | $1.5M |
| Millennium Management | 0.00% | Reduce -58.1% | 313,162 | $1.2M |
| Artal Group S.A. | 0.03% | No change | 300,000 | $1.2M |
| Pura Vida Investments, LLC | 1.26% | Reduce -41.3% | 270,618 | $1.0M |
| Frazier Life Sciences Management, L.P. | 0.05% | Reduce -11.9% | 245,692 | $1.0M |
| Vanguard Group Inc. | 0.00% | Add +20.4% | 216,166 | $882K |
| ExodusPoint Capital Management, LP | 0.01% | Reduce -15.3% | 192,763 | $786K |
| Marshall Wace, LLP | 0.00% | Reduce -7.9% | 168,639 | $688K |
| Geode Capital Management, LLC | 0.00% | Add +89.3% | 164,235 | $670K |
| Point72 Asset Management | 0.00% | Reduce -73.3% | 99,002 | $404K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +49.6% | 45,111 | $184K |
| Morgan Stanley | 0.00% | Add +385.8% | 44,718 | $182K |
| Jacobs Levy Equity Management, Inc. | 0.00% | New | 44,156 | $180K |
| Two Sigma Investments, LP | 0.00% | Add +87.0% | 37,694 | $154K |
| State Street Corp. | 0.00% | New | 30,474 | $124K |
| New York State Common Retirement Fund | 0.00% | New | 26,600 | $109K |
| Resolute Advisors LLC | 0.03% | Add +165.0% | 26,500 | $108K |
| Wells Fargo & Company | 0.00% | Add +5.7% | 26,312 | $107K |
| Hudson Bay Capital Management LP | 0.00% | Reduce -74.5% | 17,000 | $69K |
| XTX Topco Ltd | 0.01% | New | 16,244 | $66K |
| Bramshill Investments, LLC | 0.01% | Reduce -39.2% | 15,500 | $63K |
| Northern Trust Corp. | 0.00% | Add +4.2% | 13,596 | $55K |
| Squarepoint Ops LLC | 0.00% | Reduce -61.5% | 10,202 | $42K |
| Cerity Partners LLC | 0.00% | New | 10,000 | $41K |
| Rhumbline Advisers | 0.00% | New | 6,423 | $26K |
| BNP Paribas Financial Markets | 0.00% | New | 5,543 | $23K |
| Acadian Asset Management LLC | 0.00% | New | 5,440 | $22K |
| US Bancorp \de | 0.00% | No change | 4,500 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +859.4% | 4,375 | $18K |
| Corebridge Financial, Inc. | 0.00% | — | 3,395 | $14K |
| Bank of America Corp. | 0.00% | Add +4.6% | 3,295 | $13K |
| JPMorgan Chase & Co. | 0.00% | Reduce -80.4% | 2,689 | $11K |
| Point72 (DIFC) Ltd | 0.00% | New | 2,295 | $9K |
| Barclays PLC | 0.00% | New | 2,166 | $9K |
| UBS Group AG | 0.00% | Add +28.4% | 2,158 | $9K |
| Citigroup Inc. | 0.00% | Reduce -91.7% | 1,390 | $6K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -93.7% | 1,053 | $4K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 618 | $3K |
| Legal & General Group Plc | 0.00% | Reduce -95.1% | 491 | $2K |
| Royal Bank of Canada | 0.00% | New | 603 | $2K |
| California State Teachers Retirement System | 0.00% | New | 457 | $2K |
| Amalgamated Bank | 0.00% | New | 218 | $1K |
| Principal Securities, Inc. | 0.00% | No change | 54 | $220 |
| Larson Financial Group LLC | 0.00% | No change | 50 | $204 |
"% of holder's portfolio" is MGX's weight in each manager's 13F, not the share of Metagenomi Therapeutics Inc. the manager owns.